Danese S

Publishing 2013–2017

Is this you? Claim this profile
5
Articles
2,423
Reads on Journament
57
Co-authors
5
Journals

This page collects the articles indexed under the name Danese S. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 5

  1. Faculty Opinions Recommended Article: Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.
  2. Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
  3. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
  4. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
  5. Vedolizumab as induction and maintenance therapy for ulcerative colitis

Possible papers by Danese S 2

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis.
    as Silvio Danese gastroenterology 2020
    Same name only
  2. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
    as Silvio Danese Journal of Crohn s and Colitis 2010
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in